Study of possible correlation between RENAL FAILURE CHRONIC and EPADEL (ETHYL ICOSAPENTATE)
Accompanying discussion about FactMed users Questions and Concerns
About this FactMed analysis covering adverse side effect reports of EPADEL (ETHYL ICOSAPENTATE) patients who developed RENAL FAILURE CHRONIC.FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January muadili 2004 and October 2012, 2 individuals taking EPADEL (ETHYL ICOSAPENTATE) reported RENAL FAILURE CHRONIC to the FDA. A total of 77 EPADEL (ETHYL ICOSAPENTATE) drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.
FDA Research Report
In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.
Recent FactMed Activity for EPADEL (ETHYL ICOSAPENTATE)
My Patient Resources
Home - Beximco Pharmaceuticals Ltd Moxifloxacin vs ciprofloxacin coverage one Hilfe bei Scheideninfektionen und trockener Scheide
Antibiotics Buy Meds Online No Prescription
Prilosec Delayed Release Capsules and Oral Suspension
Ciprofloxacin Prices and Ciprofloxacin Coupons - GoodRx
Neurology, Week 4 Flashcards Quizlet